FIELD: medicine.
SUBSTANCE: invention proposes agent for suppression of snores noise designated for intramuscular administration. Agent comprises the highly purified clostridium toxin BONT/A or highly purified clostridium toxins BONT/B, BONT/C1, BONT/D, BONT/E, BONT/F and/or BONT/G. Also, agent can be used comprising a fused protein that involves light subunit of clostridium toxins among the group BONT/A, BONT/B, BONT/C1, BONT/D, BONT/E, BONT/F, BONT/G, TeNT, and heavy subunit of another clostridium toxin from the same group, or mixture of fused proteins, or complex comprising clostridium toxin or a fused protein, and one or more therapeutically good tolerable hemagglutinin, and/or one or more pharmaceutically good tolerable nontoxic protein. The proposed therapeutic agent expands assortment of medicinal agent used in the snore therapy. Invention can be used for suppression of snore noise.
EFFECT: enhanced effectiveness of agent.
10 cl, 3 ex
Title |
Year |
Author |
Number |
BIOPREPARATIONS COMPOSITIONS FOR INTRAVESICAL INSTILLATION |
2015 |
- Forssen Erik A.
- Khyuz Patrik M.
- Rupp Devid S.
|
RU2720991C2 |
HYBRID NEUROTOXINS |
2017 |
- Fonfria Subiros, Elena
- Burgin, David
|
RU2782382C2 |
LIQUID COMPOSITION OF NEUROTOXIN STABILIZED WITH TRYPTOPHAN OR TYROSINE |
2017 |
- Yarstad, Anders
- Friis, Anna
- Shtal, Ulf
- Gurell, Ann
- Agren, Barbro
- Edstrom, Emiliya
- Pikett, Endryu
|
RU2741497C2 |
HYBRID PROTEIN FOR INHIBITION OF DEGRANULATION OF MASTOCYTES AND ITS APPLICATION |
1999 |
- Bigal'Ke Khans
- Frevert Jjurgen
|
RU2214420C2 |
COMPOSITIONS AND METHODS FOR TOXIGENIC TESTING |
2012 |
- Dzhonson Erik Artur
- Pellett Sabin
- Uajtmarsh Regina Kler Mejer
- Tepp Uillyam Govard
|
RU2616281C2 |
CLOSTRIDIAL NEUROTOXINS WITH MODIFIED PERSISTENCE |
2009 |
|
RU2524429C2 |
SUPPRESSION OF ALLODYNIA INDUCED BY BONE CANCER |
2019 |
- Kalinichev, Mikhail
- Favre, Christine
|
RU2791640C2 |
GANGLIOSIDES FOR STANDARDIZING AND INCREASING CELL SENSITIVITY TO BOTULINUM NEUROTOXINS IN IN VITRO TEST SYSTEMS |
2015 |
- Ejzele Karl-Khajnts
- Mander Gerd
|
RU2694191C2 |
COMPOSITIONS AND METHODS FOR IMPROVING DRUG THERAPY WITH METAL ION DEPENDANT AGENTS |
2010 |
|
RU2540520C2 |
RECOMBINANT PROTEIN EXPRESSION IN DOUBLE-STRAND C FORM |
2006 |
|
RU2412253C2 |